During				After
	Raw		Adjusted		Raw		Adjusted
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Colorectal	1.00	0.77 to 1.30	0.98	0.73 to 1.31	0.96	0.73 to 1.27	0.92	0.68 to 1.24
Lung	0.80	0.61 to 1.05	0.80	0.60 to 1.08	0.71	0.53 to 0.95	0.69	0.51 to 0.94
Malignant melanoma	1.29	0.78 to 2.12	1.19	0.70 to 2.03	1.61	0.94 to 2.76	1.55	0.87 to 2.77
Head and neck	1.22	0.80 to 1.87	1.25	0.80 to 1.97	1.28	0.82 to 2.00	1.41	0.88 to 2.26
Upper gastrointestinal	0.65	0.44 to 0.97	0.62	0.41 to 0.95	0.86	0.57 to 1.30	0.81	0.53 to 1.25
Gynaecological	0.86	0.58 to 1.27	0.89	0.59 to 1.36	0.83	0.54 to 1.26	0.85	0.54 to 1.32
Urinary system	0.80	0.51 to 1.26	0.80	0.48 to 1.33	0.93	0.58 to 1.51	0.80	0.47 to 1.37
Total	0.90	0.80 to 1.01	0.90	0.77 to 1.04	0.90	0.79 to 1.02	0.90	0.77 to 1.05

Adjusted for sex, age, cancer site, comorbidity, educational level, and household income.

CPP = cancer patient pathway. OR = odds ratio. Estimates marked by bold indicate statistically significant at P<0.05 level.